Moderna
$192.57Change from previous close: −5.35%Absolute change: −$10.89
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $76.88B
- Enterprise value
- $73.03B
- P/E (trailing 12 months)
- -23.9
- Forward P/E
- -43.3
- Price/book
- 11.4
- Price/sales
- 34.5
- EV/EBITDA
- -33.3
- EV/revenue
- 32.8
Profitability and growth
- Gross margin
- -66.0%
- Operating margin
- -557.9%
- Net margin
- -141.4%
- ROE
- -39.0%
- ROA
- -13.3%
- Revenue growth (year over year)
- 2.1%
Financial health
- Total cash
- $5.14B
- Total debt
- $1.29B
- Debt/equity
- 0.19
- Current ratio
- 2.30
- Quick ratio
- 2.07
Dividends
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $120.67
- Median price target
- $125.00
- High price target
- $170.00
- Low price target
- $45.00
- Analysts with a price target
- 18
- Consensus
- Hold
- Forward EPS
- -$4.45
- EPS estimate, current year
- -$8.39
Shares and trading
- Beta
- 1.11
- Average volume
- 17.21M
- Shares outstanding
- 399.24M
- Float
- 372.19M
- Institutional ownership
- 80.5%
- Insider ownership
- 7.3%
- Short interest (% of float)
- 10.1%
- Short ratio (days)
- 0.99